Two different answers to the same problem

If your surgeon has raised both AMIC and OATS as possibilities for your hip, the question you are really asking is not which procedure is better — it is which one matches the specific damage inside your joint.

The two techniques sit at the more advanced end of the hip cartilage repair pathway, beyond plain microfracture, and both are aimed at younger, active patients who want to delay or avoid hip replacement. That is where the similarity largely ends. AMIC is designed for defects that are chondral — affecting cartilage only, most often on the socket side of the joint (the acetabulum). OATS is designed for osteochondral defects, where the damage extends through the cartilage into the underlying bone, most commonly on the femoral head.

Because the procedures address structurally different problems, the decision turns on the anatomy of the defect — its depth, location, and size — rather than on personal preference or surgical fashion. Both aim to restore a durable joint surface in a hip with a focal injury, not diffuse osteoarthritis. This article works through the clinical logic that distinguishes the two.

What AMIC does and when it fits

The procedure works in two sequential steps within a single operation. First, the surgeon performs microfracture — small perforations through the base of the defect that open channels into the bone marrow. The clot that forms carries mesenchymal stem cells capable of differentiating into repair tissue. In plain microfracture, that clot is unstable and tends to produce fibrocartilage rich in type I collagen — structurally weaker than native hyaline cartilage and prone to deterioration within two to three years. AMIC addresses this by placing a bi-layer collagen I/III scaffold (such as Chondro-Gide) directly over the defect: the membrane stabilises the clot, retains the stem cells at the repair site, and guides differentiation toward collagen II-enriched tissue — closer in composition to native cartilage, though not identical to it.

The technique is indicated for full-thickness chondral defects of at least 2 cm², particularly acetabular rim lesions arising in the context of femoroacetabular impingement, where the subchondral bone remains intact and no bone grafting is required.

Hip-specific evidence is encouraging. A 2019 prospective study of 62 recreational athletes with full-thickness acetabular defects reported HOOS (a 0–100 hip function score, where higher scores reflect better function) rising from 58.8 to 90.6, and mHHS (modified Harris Hip Score, where a result above 80 is generally considered good) improving from 53.4 to 82.4 at over two years of follow-up; VAS pain fell from 4.9 to 1.1 out of 10. A 2023 mid-term series of ten FAI hips at five-year follow-up recorded a MOCART score of 67.5 — an MRI-based measure of cartilage fill on a 0–100 scale, where scores above 60 indicate meaningful tissue restoration — with no revision surgery required in that series.

A 2025 systematic meta-analysis of 628 hips positioned AMIC ahead of plain microfracture and two-stage cell therapy for this defect profile, reporting a pooled success rate of 99.6% and a mean mHHS gain of 35.8 points. Registry data from 57 patients with a mean defect size of 3.4 cm² confirms the technique scales to larger lesions that would exceed the donor volume available for OATS.

What OATS does and when it fits

The structural logic behind OATS starts with the defect itself. Rather than stimulating the body to produce repair tissue, OATS transplants genuine osteochondral material — a plug of hyaline cartilage with its intact bone base — directly into the damaged area. Because the plug arrives with its own structural foundation, it replaces both the cartilage surface and the compromised subchondral bone beneath it. That makes it the appropriate choice when bone support has already been lost, not a situation AMIC is designed to address.

In the hip, accessing the femoral head for plug implantation requires an open, vessel-sparing surgical dislocation — a technique that temporarily moves the femoral head from the socket without disrupting its blood supply. Arthroscopic delivery has been described, but it remains technically demanding and less widely performed. Specialist centres conducting hip preservation surgery carry out the open approach routinely, though the operation is more extensive than the arthroscopic access used for most AMIC cases.

OATS is best suited to full-thickness osteochondral defects of the femoral head — post-traumatic lesions, osteonecrosis (avascular necrosis), and osteochondritis dissecans — where the damage extends through the cartilage into the bone itself.

Long-term outcome data, though drawn from small series, are encouraging. A 2025 multicenter study followed eight autograft-treated hips to a mean of 9.5 years; mHHS was 87.6, HOS-ADL 92.7, and HOS-SSS 83.1 — all in the good-to-excellent range — and none of the eight patients required conversion to total hip arthroplasty over that period.

The principal constraint is defect size. Mean autograft dimensions in that series were 1.6 × 1.0 cm, which reflects a fundamental limit on available donor volume. OATS is generally confined to defects under approximately 2 cm²; beyond that threshold, autograft tissue becomes insufficient and allograft or cell-based strategies are typically required instead.

Patients sometimes ask where the donor plug comes from. Conventionally it is harvested from the ipsilateral knee, which introduces a second source of surgical morbidity. A modified technique — harvesting from the non-load-bearing portion of the same femoral head during surgical dislocation — has been described for osteonecrosis cases, with Harris Hip Score improving from 64 to 82 at 36 months and no separate knee incision required. This remains an emerging rather than routine approach, but it illustrates how the technique continues to evolve around its own limitations.

How the choice is made in practice

Selecting between the two procedures is a specialist-led process driven by imaging and clinical assessment — it is not a choice patients are expected to make themselves. The decision follows a logical sequence of filters, each one narrowing the options before the next is applied.

Location comes first. Lesions on the acetabular surface, particularly rim damage associated with FAI, point toward AMIC. Lesions on the femoral head, especially where the bone itself is implicated, point toward OATS. The different anatomical targets reflect each technique's structural logic, which earlier sections cover in detail.

Depth follows. If the defect is chondral-only — full-thickness cartilage loss but with the subchondral bone plate intact — AMIC is typically the direction taken. Once there is meaningful osteochondral depth, with bone loss beneath the cartilage surface, OATS becomes the more appropriate tool because it restores the bone foundation as well as the surface.

Size then sets the boundary. AMIC can be applied to defects from around 2 cm² and scales to larger lesions; OATS is practically limited to roughly 2 cm² or less by the volume of autograft available. Larger femoral head defects generally require allograft variants or cell-based techniques rather than either procedure.

Joint congruity acts as a shared gate for both. A Tönnis grade of 0 or 1 — indicating a well-preserved joint space with minimal osteoarthritic change — is the appropriate setting. Tönnis grade 2 or above removes a patient from the cartilage repair pathway entirely; diffuse osteoarthritis is not amenable to focal restoration.

Age and activity level complete the picture. Both procedures are best suited to patients typically under 50 with focal symptomatic defects and realistic rehabilitation expectations. Older patients, or those with wider joint degeneration, are more likely to be assessed for hip replacement rather than preservation.

Where FAI is the underlying cause, correction of the bony impingement is usually incorporated into the same procedure — addressing the mechanical driver of cartilage damage at the same time as the cartilage defect itself.

Recovery timelines and what to expect

Protected weight-bearing is the shared starting point for both procedures, though the two timelines diverge from there in ways that matter for practical planning.

After AMIC, crutches and restricted loading typically continue for around six to eight weeks. Low-impact activity — swimming, cycling — is generally realistic by three to four months. Return to sport, where applicable, falls within nine to twelve months in published series. At twelve months, MRI using MOCART scoring is used to assess how well the repair tissue has filled the defect; a five-year FAI series recorded a mean MOCART of 67.5, confirming adequate tissue presence. Matched cohort data shows higher return-to-sport rates after AMIC than after plain microfracture in active patients, though this applies to focal defects in well-preserved hips and may not reflect every patient's situation.

After OATS, full weight-bearing takes longer — published series report averages of 9.8 to 10.2 weeks — because osteochondral plug integration into host bone requires additional biological time beyond what scaffold-only repair demands. Return to sport follows a broadly similar overall timeline to AMIC; one case series reported a mean of 9.5 months, though the hip-specific evidence base for OATS remains smaller.

For both procedures, physiotherapy-led rehabilitation — range-of-motion exercises, progressive loading, and muscle strengthening — is an active component of treatment, not a passive waiting period. How closely patients follow this programme materially affects the outcome. Pain and swelling in the first few weeks after either operation are expected and should not be interpreted as a sign that the repair has failed.

When to seek a specialist hip assessment

Deciding whether cartilage repair is worth exploring starts with an assessment that establishes what kind of damage is present — and whether it is focal and restorable.

That assessment typically combines clinical examination with dedicated hip MRI, including cartilage-specific sequences where indicated. Any prior imaging, arthroscopy reports, or previous microfracture procedures form part of the review, since earlier marrow-stimulation work directly affects which repair options remain viable. Patients whose imaging shows moderate joint-space narrowing consistent with Tönnis grade 2 or above are generally outside the cartilage repair pathway; that distinction is one the assessment is specifically designed to make, and it cannot be drawn from symptoms alone.

Not every patient referred for this kind of evaluation will turn out to be a candidate for AMIC or OATS. Where diffuse joint change is the predominant finding, the assessment redirects toward hip replacement planning rather than preservation — an honest outcome that is itself clinically useful.

Lincolnshire Hip is part of the MSK Doctors group and accepts patients without referral for hip assessment, with clinics in Sleaford and Grantham serving patients across Lincolnshire and the wider non-London UK catchment. Prof Paul Y. F. Lee's practice centres on hip cartilage preservation and joint-preserving hip surgery.

1. [1] Osteochondral Allograft and Autograft Transplant for Femoral Head Defects: A Multicenter Study (2025). (2025). https://doi.org/10.1177/03635465251338062 https://doi.org/10.1177/03635465251338062
2. [2] A Technique for Arthroscopic Osteochondral Autograft Transplantation of the Hip (2019). (2019). https://doi.org/10.1016/j.eats.2018.09.008 https://doi.org/10.1016/j.eats.2018.09.008
3. [3] Mid-term results of AMIC for large chondral defects in FAI hips (2023). (2023). https://doi.org/10.1302/1358-992x.2023.12.029 https://doi.org/10.1302/1358-992x.2023.12.029
4. [4] FP5.8 Osteochondral Allograft and Autograft Transplantation for Femoral Head Defects – Mean 5-Year Follow-Up (2025). (2025). https://doi.org/10.1093/jhps/hnaf011.046 https://doi.org/10.1093/jhps/hnaf011.046
5. [5] Arthroscopic AMIC vs Microfracturing for Acetabular Cartilage Lesions in Cam-type FAI (2016). (2016). https://doi.org/10.17265/2332-7839/2016.01.002 https://doi.org/10.17265/2332-7839/2016.01.002
6. [6] Traumatic Osteochondral Injury of the Femoral Head Treated by Mosaicplasty (2010). (2010). https://doi.org/10.1007/s11420-010-9159-y https://doi.org/10.1007/s11420-010-9159-y
7. [7] Autologous matrix-induced chondrogenesis (Wikipedia). https://en.wikipedia.org/?curid=29760859 https://en.wikipedia.org/?curid=29760859
8. [8] Modified OAT for steroid-induced osteonecrosis of femoral head – case report (2024). (2024). https://doi.org/10.1186/s12891-023-07108-z https://doi.org/10.1186/s12891-023-07108-z
9. [9] Microfracture Augmented with Allograft Cartilage (BioCartilage) for Hip Chondral Defects – 5-Year Outcomes (2025). (2025). https://doi.org/10.1177/2325967125s00203 https://doi.org/10.1177/2325967125s00203